Articles related to NEURODEGENERATIVE DISEASES

Recent research suggests that promoting neuroplasticity through various techniques may offer new treatment possibilities for patients with neurodegenerative diseases, developmental disorders, and mental health conditions.

Nicotinamide supplementation has been linked to improvements in neurodegenerative symptoms by addressing amyloid-beta and tau pathologies, neuroinflammation, and mitochondrial dysfunction, offering potential therapeutic benefits for conditions like Alzheimer’s disease.

Understanding the potential impact of household chemical exposures on ALS risk underscores the importance of environmental assessments in neurological care.

The latest advancements in MRI technology are offering unparalleled insights into the brain’s anatomy, promising to enhance our diagnostic and therapeutic strategies for a range of neurological and psychiatric conditions.

This study unveils a blood-based biomarker test capable of identifying individuals at risk of Parkinson’s Disease and related dementias with remarkable precision, promising a new era in the proactive management of neurodegenerative disorders.

A groundbreaking study in The Lancet Neurology reports that 94% of patients with posterior cortical atrophy also have Alzheimer’s disease pathology, stressing the need for heightened awareness among clinicians for earlier diagnosis and intervention.